Member Info for BlackJack

Well now that has changed the tide of falling shares over 500k traded and look the shares have bounced and a good one at that, results due on the 6th , Hope you guys cut off your positions while the shares where at £23.20 and not at £26.80 looks like this one is heading back up.

The report from Matt Earl has sent the share price down which we have all seen, perhaps the company was a little overvalued, but I think it will level off, The founder owns 30% of the shares and other major shareholders own a further 20% now if you look on the news feed , not one of these major shareholders has changed their holdings so they are not convinced by the likes of MATT Earl nor am I he is trying to stitch a few things together to beef up his report. FD on the other hand is recruiting 1000 graduates over the next few years, it is buying the remaining % of Kx it does not already own and it trades worldwide so is not going to be effected too much by Brexit or only in a positive way IMHO. I think it is a well run company that has expanded organically and through aquisitions, more shares have been bought than sold in the last couple of days and today so lets see if any of the big shareholders add to their postions or sell shall we.

Looking forward to a trading update this week should be interesting to see how the business has performed with the addition of H Peel and Sons.

Spiced Rum, long the forgotten sub-category from warmer climes, is now pushing to be the next big thing. Rum as a whole is in fantastic growth, but it is spiced rum that is climbing the fastest � coming in several variants from vanilla-led, dark cinnamon and clove infused to those with an almost chili heat. Many bars are even infusing their own for a personalised twist � just ask one of spirits team to help build a recipe. https://www.enotriacoe.com/blog/2018-market-trends. Found this article this morning Spiced Rum is set to be the next big thing "Red Leg " should get a boost from this .

Is it time to buy on todays election uncertainty or is this share going to bomb and then be a target for a takeover it is still making money but margins are being squeezed by the fall in stirling against dollar and euro, if they stop the dividend it will bomb out in my opinion. might dip my toe if it goes to 8.00p

Looks like this share is on the rise again with a few new contracts in the last month and interims on the way maybe a dividend will resume in the next six months, I like this small cap for its diversity .

I agree Sandhopper a real slow burner, I think alot of people don't understand this company, but todays announcement is good because it comes on the back of President Trumps sabre rattling on Health Care reforms , I would be pretty sure he is not going to hit this company with his reforms because it provides a unique and patented product in DCELL that cannot be provided by any other company and is superb as a money saver in that once administered to the patient it requires no further anti rejection drugs once the wound is healed.

Yes Sandhopper forgot to mention that Neil Woodford agrees, slowly increasing his stake 1% at a time.

I am sure this will be on a few New Year share tipers lists. Now that dermapure product is ramping up the number of distributors in the USA including the second largest Premier Inc, the OrthoPure XT is about to get approval from both the US and the EU this should see revenues really start to climb from this company and its world class products 2017 should be a great year for TRX and its share holders.

This company is getting going, yes it is burning cash but the potential of its products is huge and unlike others in the market because its products are not rejected by the body which is a win win situation no furhter operations or drugs to be taken to stop rejection of foreign tissues. The process they use decellurarises the human and animal tissue providing a neutral scaffold thus enabling the body to repair itself more easily without tissue rejection. It has Medicare coverage of 93% of the USA market for one of its products Dermapure which is used to heal wounds that occur on diabetics and the long term ill . Also its other products for heart valve and ligament replacement are close to market . I say get in while you can.

Kainos spent �900,000 in February 2016 and bought a 10% shareholding in Cirdan Imaging Ltd headed up by Hugh Cormican . Hugh Cormican is the former CEO of Andor Technology PLC which was floated on the stock exchange and subsequently sold to Oxford Instruments PLC, he is a big fan of floating companies on the stock exchange so this 10% stake is a clever investment by Kainos which they should profit from handsomely in due course.

Neil Woodford investment takes another small bite of TRX incresing group holding to above 18% from 17.65% 18th July 2016

At last the market has woken up and taken notice of this share it is now starting to turn its research into cash producing products dcell wound care has over $1m in sales up to January this year with other very innovative prducts that patients bodies don't reject in the pipeline.

Well observed its only midday lets see how it goes for the rest of the day.

Tissue Regenix releases 2 pieces of good news today further medicare coverage in the US for its Demapure product another 4.40million medicare patients or 74% coverage and FDA approval for Surgipure http://www.lse.co.uk/share-regulatory-news.asp?shareprice=TRX&ArticleCode=6tdzdphr&ArticleHeadline=510k_market_clearance_granted_for_SurgiPureT_XD

topped up our holdings in these today as dividend will be paid to those on register at 4th March but trades are not showing brokers must be up to a hiding game . The only way is up.

Just bought 3270 of these shares and they have gone through on the market as a sell very strange got them at a great price though of .01780 p plus dealing , just cannot understand why they have gone through as a sell and not a buy.

Look at this article Liad Madar a fund manager bought 1million shares in the company just 4 days ago taking his holding over 4% http://shares.telegraph.co.uk/news/article.php?id=4708981&epic=FCCN. This is an interesting move. He obviously has faith in this company as a recovery buy too.

The CBI report is all well and good but what you need to take into account is this, French Connection has been completely restructured since the down turn the board has been restructured too and the fruits of this are going to be showing in the next results. Look at the level of trading in the shares it has been just shy of 3,000,000 in the last 2 trading days now with only 95.9m shares in issue that is a pretty impressive volume considering the shares in this company normally trade in the thousands over the course of a week not millions.

http://www.telegraph.co.uk/finance/newsbysector/retailandconsumer/10392295/Zigzag-pattern-that-is-French-Connection.html This was in the Telegraph 6 days ago .